Home

  • Order to parcel locker

    Order to parcel locker

  • easy pay

    easy pay
  • PZWL
  • Reduced price
Fibroblast Activation Protein Imaging, An Issue of PET Clinics

Fibroblast Activation Protein Imaging, An Issue of PET Clinics

9780323938952
PRINT ON DEMAND - DELIVERY CAN TAKE UP TO 14 DAYS
396.84 zł
337.32 zł Save 59.52 zł Tax included
Lowest price within 30 days before promotion: 337.32 zł
Quantity
Available in 4-6 weeks

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
In this issue, guest editors bring their considerable expertise to this important topic.
Product Details
Elsevier
99439
9780323938952
9780323938952

Data sheet

Publication date
2023
Issue number
1
Cover
hard cover
Pages count
240
Dimensions (mm)
178 x 254
Weight (g)
450

  • Advanced Fibroblast Activation Protein-Ligand Developments: FAP Imaging Agents: A Review of the Structural Requirements

    Fibroblast Activation Protein Inhibitor PET in Pancreatic Cancer

    The Diagnostic Value of Fibroblast Activation Protein Imaging in Hepatocellular Carcinoma and Cholangiocellular Carcinoma

    Fibroblast Activation Protein Inhibitor PET Imaging in Head and Neck Cancer

    Fibroblast Activation Protein Inhibitor-PET Imaging in Colorectal Cancer

    Fibroblast Activation Protein Inhibitor PET/CT in Gastric Cancer

    Current Status of Fibroblast Activation Protein Imaging in Gynecologic Malignancy and Breast Cancer

    Fibroblast Activation Protein Inhibitor (FAPI)-PET Imaging in Sarcoma

    Fibroblast Activation Protein Inhibitor Theranostics: The Case for Use in Sarcoma

    Radiation Therapy Planning Using Fibroblast Activation Protein Inhibitor

    Imaging Fibrosis

    Cardiac Applications of Fibroblast Activation Protein Imaging

    Fibroblast Activation Protein Inhibitor Theranostics: Preclinical Considerations

    Fibroblast Activation Protein Inhibitor Theranostics: Preclinical Combination Treatment

    Fibroblast Activation Protein Inhibitor Theranostics: Early Clinical Translation

    Current State of Clinical Trials and Regulatory Approvals with Fibroblast Activation Protein Targeting Interventions

Comments (0)
Viewed products

  • Frequently purchased together

    No products available